Cusick v. GlaxoSmithKline, LLC et al
| Gaylon Cusick |
| GlaxoSmithKline, LLC, Pfizer, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, Sanofi-Aventis U.S. LLC, Sanofi U.S. Services, Inc. and Patheon Manufacturing Services LLC |
| 1:2024cv00215 |
| February 16, 2024 |
| US District Court for the District of Delaware |
| Maryellen Noreika |
| Personal Inj. Prod. Liability |
| 28 U.S.C. ยง 1332 Diversity-Notice of Removal |
| Both |
Docket Report
RSS Track this Docket
This docket was last retrieved on March 8, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 8 CONDITIONAL TRANSFER ORDER - This case is hereby transferred to the United States District Court for the Southern District of Florida. Signed by Tiffaney D. Pete, Clerk of the Multidistrict Litigation Panel on 3/6/2024 and certified by the Clerk of the United States District Court for the Southern District of Florida 3/7/2024. ***Civil Case Terminated. (dlw) |
| CASE CLOSED (dlw) |
| Remark: Case transferred from Delaware has been opened in Southern District of Florida as case 9:24-cv-80271, filed 03/08/2024. (nmg) |
| Filing 7 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent DPI Newco LLC, Other Affiliate Thermo Fisher Scientific Inc. for Patheon Manufacturing Services LLC filed by Patheon Manufacturing Services LLC. (O'Kelly, Sean) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sanofi SA for Sanofi U.S. Services, Inc., Sanofi-Aventis U.S. LLC filed by Sanofi U.S. Services, Inc., Sanofi-Aventis U.S. LLC. (Rappaport, Nancy) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent GlaxoSmithKline plc. for GlaxoSmithKline, LLC filed by GlaxoSmithKline, LLC. (Brannigan, Patrick) |
| Filing 4 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Pfizer, Inc.. (Brown, Daniel) |
| Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) |
| Filing 3 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Boehringer Ingelheim USA Corporation for Boehringer Ingelheim Pharmaceuticals, Inc. filed by Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation. (vfm) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) |
| Filing 1 NOTICE OF REMOVAL and copies of documents from Superior Court of the State of Delaware, Case Number N24C-01-112 ZAN (Filing fee $405, receipt number ADEDC-4341408)- filed by Pfizer, Inc., GlaxoSmithKline, LLC, Sanofi-Aventis U.S. LLC, Sanofi U.S. Services, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Civil Cover Sheet #6 Certificate of Service) (vfm) |
| DEFICIENCY NOTICE issued by the Court to Defendant's: GlaxoSmithKline, LLC, Pfizer, Inc., Sanofi-Aventis U.S. LLC, Sanofi U.S. Services, Inc. and Patheon Manufacturing Services LLC: Pursuant to Fed. R. Civ. P. 7.1 (b)(1), A party must: (1) file the disclosure statement with its first appearance, pleading, petition, motion, response, or other request addressed to the court. Counsel is requested to supplement the docket with an appropriate Rule 7.1 Disclosure Statement. (vfm) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
